Annandale Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Annandale Capital's JNJ Position: Q2 2026 in Review
Annandale Capital reduced its Johnson & Johnson (JNJ) stake by 0.14% in Q2 2026, selling an estimated $6.99K and leaving 20,987 shares worth $5.33M. The position accounts for 0.73% of the portfolio, ranked #40.
Annandale Capital first reported a position in JNJ in Q4 2020 and has held it in 23 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Annandale Capital held 20,987 shares of Johnson & Johnson worth $5.33M as of Q2 2026.
- Annandale Capital sold 30 Johnson & Johnson shares in Q2 2026, an estimated $6.99K.
- Johnson & Johnson made up 0.73% of Annandale Capital's portfolio in Q2 2026, its #40 holding.
- Annandale Capital first reported a position in Johnson & Johnson in Q4 2020 and has held it in 23 quarters since.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Annandale Capital's 13F filing for Q2 2026, filed 13 Aug 2026.